Gene content    
APC ( by HUGO)
Adenomatous Polyposis Coli
Tumor suppressor gene
Adenomatous Polyposis Coli
Deleted In Polyposis 2.5
DP2.5
BTPS2
GS
Adenomatosis Polyposis Coli
Protein Phosphatase 1
Regulatory Subunit 46
DP2
DP3
PPP1R46
Adenomatosis Polyposis Coli Tumor Suppressor
Adenomatous Polyposis Coli Protein
Protein Phosphatase 1
Regulatory Subunit 46
Protein APC
FPC
NCBI: 5q21-q22    Ensembl: 5q22.2
APC_HUMANSize: 2843 amino acidsMass: 311646 Da

  • Subunit: Forms homooligomers and heterooligomers with APC2. Interacts with DIAPH1 and DIAPH2 (By similarity). Interacts with PDZ domains of DLG1 and DLG3. Associates with catenins. Binds axin. Interacts with ARHGEF4 (via N-terminus). Interacts with MAPRE1 (via C-terminus); probably required for APC targeting to the growing microtubule plus ends. Interacts with MAPRE2 and MAPRE3 (via C-terminus). Found in a complex consisting of ARHGEF4, APC and CTNNB1. Interacts with SCRIB; may mediate APC targeting to adherens junctions of epithelial cells. Interacts with SPATA13 (via N-terminus and SH3 domain). Interacts with ASAP1 (via SH3 domain). Found in a complex composed of MACF1, APC, AXIN1, CTNNB1 and GSK3B (By similarity). Interacts at the cell membrane with AMER1 and AMER2 (via ARM repeats) Miscellaneous: APC mutations have led to some interesting observations. (1) the great majority of the mutations found to date would result in truncation of the APC product. (2) almost all the mutations have occurred within the first half of the coding sequence, and somatic mutations in colorectal tumors are further clustered in a particular region, called MCR (mutation cluster region). (3) most identified point mutations in the APC gene are transitions from cytosine to other nucleotides. (4) the location of germline mutations tends to correlate with the number of colorectal polyps in FAP patients. Inactivation of both alleles of the APC gene seems to be required as an early event to develop most adenomas and carcinomas in the colon and rectum as well as some of those in the stomach Selected PDB 3D structures from [IMAGE] and Proteopedia [IMAGE] for APC (see all 17): 1DEB (3D) [IMAGE] 1EMU (3D) [IMAGE] 1JPP (3D) [IMAGE] 1M5I (3D) [IMAGE] 1T08 (3D) [IMAGE] 1TH1 (3D) [IMAGE]
  • Tissue specificity: Expressed in a variety of tissues [IMAGE] Pathway & Disease-focused RT2 Profiler PCR Arrays including APC (see all 15): Parkinson's Disease in human mouse rat Oncogenes & Tumor Suppressor Genes in human mouse rat Lung Cancer in human mouse rat Multiple Sc
  • Function:
    UniProtKB/Swiss-Prot Summary: APC_HUMAN, P25054 Function: Tumor suppressor. Promotes rapid degradation of CTNNB1 and participates in Wnt signaling as a negative regulator. APC activity is correlated with its phosphorylation state. Activates the GEF activity of SPATA13 and ARHGEF4. Plays a role in hepatocyte growth factor (HGF)-induced cell migration. Required for MMP9 up-regulation via the JNK signaling pathway in colorectal tumor cells. Acts as a mediator of ERBB2-dependent stabilization of microtubules at the cell cortex. It is required for the localization of MACF1 to the cell membrane and this localization of MACF1 is critical for its function in microtubule stabilization
  • Similarity:
    Belongs to the adenomatous polyposis coli (APC) family
                          
    Contains 7 ARM repeats [IMAGE]
  • Protein Domain/Family    
    Source ID Domain Name Type
    InterProIPR000225ArmadilloArmadilloRepeat
    IPR009223APC_Cys-rich_rptAPC cysteine-richRepeat
    IPR009224SAMPSAMPRepeat
    IPR009232EB1-bdEB-1 bindingDomain
    IPR009234APC_basic_domAPC basicDomain
    IPR009240APC_15aa_rptAPC 15 residueRepeat
    IPR011989ARM-likeArmadillo-like helicalDomain
    BlocksIPB000225Armadillo repeatArmadillo repeat

    Gene Ontology    
    Type Term Evidence Source Pub
    Biological Process canonical Wnt signaling pathway NAS GOA 11035805
    canonical Wnt signaling pathway IC GOA 9601641
    cell adhesion NAS GOA 8259518
    cell cycle arrest IDA GOA 8521819
    cell migration IMP GOA 19151759
    cellular response to DNA damage stimulus IDA GOA 14728717
    mitotic cytokinesis IMP GOA 17570218
    mitotic spindle assembly checkpoint IMP GOA 17227893
    negative regulation of canonical Wnt signaling pathway IGI GOA 12952940
    negative regulation of cell proliferation IDA GOA 8521819
    negative regulation of cyclin-dependent protein serine/threonine kinase activity IDA GOA 8521819
    negative regulation of microtubule depolymerization IMP GOA 17192415
    negative regulation of microtubule depolymerization IDA GOA 11166179
    positive regulation of apoptotic process IMP GOA 17227893
    positive regulation of cell migration IMP GOA 17192415
    positive regulation of protein catabolic process IGI GOA 12952940
    positive regulation of protein catabolic process IC GOA 16188939
    positive regulation of pseudopodium assembly IMP GOA 17192415
    protein complex assembly IDA GOA 16188939
    regulation of attachment of spindle microtubules to kinetochore NAS GOA 11283619
    regulation of attachment of spindle microtubules to kinetochore IMP GOA 17227893
    tight junction assembly NAS GOA 18502210
    Cellular Component beta-catenin destruction complex IDA GOA 16188939
    centrosome IDA GOA 11283619
    colocalizes_with cell-cell adherens junction IDA GOA 16611247
    colocalizes_with plasma membrane IDA GOA 16611247
    cytoplasm IDA GOA 11035805
    kinetochore IDA GOA 11283619
    lamellipodium IDA GOA 19151759
    lateral plasma membrane IDA GOA 12072559
    nucleus IDA GOA 11035805
    ruffle membrane IDA GOA 19151759
    tight junction IDA GOA 18502210
    Molecular Function beta-catenin binding IPI GOA 10773885
    gamma-catenin binding IPI GOA 7890674
    microtubule binding IDA GOA 11166179
    microtubule plus-end binding IDA GOA 19632184
    NOT cadherin binding IDA GOA 7890674
    protein binding IPI GOA 10656683
    protein kinase binding IPI GOA 8638126
    protein kinase regulator activity IDA GOA 11972058

    Disorder & Mutation    
    Source Disease
    SWISS-PROTMismatch repair cancer syndrome (MMRCS) [MIM:276300]: Autosomal dominant disorder characterized by malignant tumors of the brain associated with multiple colorectal adenomas. Skin features include sebaceous cysts, hyperpigmented and cafe au lait spots. Note=The disease is caused by mutations affecting the gene represented in this entry
    SWISS-PROTGastric cancer (GASC) [MIM:613659]: A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease. Note=The gene represented in this entry may be involved in disease pathogenesis
    SWISS-PROTMedulloblastoma (MDB) [MIM:155255]: Malignant, invasive embryonal tumor of the cerebellum with a preferential manifestation in children. Note=The gene represented in this entry may be involved in disease pathogenesis
    SWISS-PROTHereditary desmoid disease (HDD) [MIM:135290]: Autosomal dominant trait with 100% penetrance and possible variable expression among affected relatives. HDD patients show multifocal fibromatosis of the paraspinal muscles, breast, occiput, arms, lower ribs, abdominal wall, and mesentery. Desmoid tumors appears also as a complication of familial adenomatous polyposis. Note=The disease is caused by mutations affecting the gene represented in this entry
    SWISS-PROTFamilial adenomatous polyposis (FAP) [MIM:175100]: A cancer predisposition syndrome characterized by adenomatous polyps of the colon and rectum, but also of upper gastrointestinal tract (ampullary, duodenal and gastric adenomas). This is a viciously premalignant disease with one or more polyps progressing through dysplasia to malignancy in untreated gene carriers with a median age at diagnosis of 40 years. Note=The disease is caused by mutations affecting the gene represented in this entry

    APC cross reference    
    PubMed OMIM Entrez Gene NCKU SNP Nucleotide UniProt Genome Data Viewer HomoloGene